Cargando…
B cell depletion therapy does not resolve chronic active multiple sclerosis lesions
BACKGROUND: Chronic active lesions (CAL) in multiple sclerosis (MS) have been observed even in patients taking high-efficacy disease-modifying therapy, including B-cell depletion. Given that CAL are a major determinant of clinical progression, including progression independent of relapse activity (P...
Autores principales: | Maggi, Pietro, Bulcke, Colin Vanden, Pedrini, Edoardo, Bugli, Céline, Sellimi, Amina, Wynen, Maxence, Stölting, Anna, Mullins, William A., Kalaitzidis, Grigorios, Lolli, Valentina, Perrotta, Gaetano, El Sankari, Souraya, Duprez, Thierry, Li, Xu, Calabresi, Peter A., van Pesch, Vincent, Reich, Daniel S., Absinta, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436266/ https://www.ncbi.nlm.nih.gov/pubmed/37437310 http://dx.doi.org/10.1016/j.ebiom.2023.104701 |
Ejemplares similares
-
BMAT: An open-source BIDS managing and analysis tool
por: Vanden Bulcke, Colin, et al.
Publicado: (2022) -
Acute Susac Syndrome in a Recent User of Adulterated Cocaine: Levamisole as a Triggering Factor?
por: De Baerdemaeker, Klara, et al.
Publicado: (2020) -
Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
por: Druart, Charlotte, et al.
Publicado: (2017) -
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
por: Guilmot, Antoine, et al.
Publicado: (2020) -
Improvement in progressive multifocal leukoencephalopathy after pembrolizumab‐induced immune reconstruction inflammatory syndrome in a patient with follicular lymphoma
por: Dufour, Inès, et al.
Publicado: (2020)